Phathom will showcase its growing leadership in GI through multiple engagements with the medical and scientific community, including a product theater presentation highlighting VOQUEZNA ® (vonoprazan) ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) invests $4 million in exchange for a 30% ownership stake and joint control in RedHill's Talicia business U.S. co-commercialization ...

GRAND JUNCTION, Colo. (KJCT) - Over 70 Grand Valley residents who identify as low vision or support the community attended ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS ...

DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...

A carefree vacation clip has taken on a haunting significance for a millennial mom, who later learned it captured the early signs of melanoma.

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as ...

G RAND JUNCTION, Colo. (KKCO) - Over 70 Grand Valley residents who identify as low vision or support the community attended ...

Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.